A delayed-start design has been proposed to assess a potential disease-modifying effect in investigational drugs for Alzheimer’s disease that target the underlying disease process. EXPEDITION3 was a Phase 3, double-blind study with participants randomized to solanezumab (400 mg) or placebo… Continue Reading →
The objectives of the present study are to investigate the changes in specific domains of cognitive function in older adults reporting subjective memory complaints with a low omega-3 index receiving omega 3 polyunsaturated fatty acid (n-3 PUFA) supplementation or placebo…. Continue Reading →
Over this century we can expect to see older persons live longer, be more resilient and less frail. Research and care have been built to identify and treat diseases, but not to maintain functional capacities (eg, mobility, cognition, immune functions,… Continue Reading →
© 2025 Aging-news